CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 8, 2006, Pages 3400-3409

  Lepisto, Andrew J ^a   Frank, Gregory M ^a   Xu, Min ^b   Stuart, Patrick M ^c   Hendricks, Robert L ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES STROMAL KERATITIS; HISTOPATHOLOGY; IMMUNOPATHOLOGY; INCIDENCE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; CORNEA STROMA; DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METHODOLOGY; MOUSE MUTANT; PHYSIOLOGY; VIROLOGY;

ANIMALS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CORNEAL STROMA; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 1, HUMAN; INTERFERON TYPE II; KERATITIS, HERPETIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT;

EID: 33748106527     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0898     Document Type: Article

References (27)

1. Metcalf JF, Hamilton DS, Reichert RW. Herpetic keratitis in athymic (nude) mice. Infect Immun. 1979;26:1164-1171.
2. Russell RG, Nasisse MP, Larsen HS, et al. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 1984;25:938-944.
3. Newell CK, Martin S, Sendele D, et al. Herpes simplex virusinduced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol. 1989;63:769-775.
4. Hendricks RL, Tumpey TM. Contribution of virus and immune factors to herpes simplex virus type 1 induced corneal pathology. Invest Ophthalmol Vis Sci. 1990;31:1929-1939.
5. Mercadal CM, Bousley DM, Destephano D, et al. Herpetic stromal keratitis in the reconstituted SCID mouse model. J Virol. 1993;67:3404-3408.
6. Hendricks RL, Tumpey TM, Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol. 1992;149:3023-3028.
7. Tang Q, Hendricks RL. IFN-gamma regulates PECAM-1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med. 1996;184:1435-1447.
8. Tang Q, Chen W, Hendricks RL. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol. 1997;158:1275-1283.
9. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol. 1992;149:3035-3039.
10. Ghiasi H, Cai S, Perng GC, et al. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br J Ophthalmol. 2000;84:408-412.
11. Banerjee K, Biswas PS, Kumaraguru U, et al. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J Immunol. 2004;173:7575-7583.
12. Avery AC, Zhao Z-S, Rodriguez A, et al. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 1995;376:431-433.
13. Zhao Z-S, Granucci F, Yeh L, et al. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 1998;279:1344-1347.
14. Panoutsakopoulou V, Sanchirico ME, Huster KM, et al. Analysis of the relationship between viral infection and autoimmune disease. Immunity. 2001;15:137-147.
15. Huster KM, Panoutsakopoulou V, Prince K, et al. T cell-dependent and -independent pathways to tissue destruction following herpes simplex virus-1 infection. Eur J Immunol. 2002;32:1414-1419.
16. Gangappa S, Babu JS, Thomas J, et al. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J Immunol. 1998;161:4289-4300.
17. Gangappa S, Deshpande SP, Rouse BT. Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. Eur J Immunol. 1999;29:3674-3682.
18. Haskova Z, Usiu N, Pepose JS, et al. CD4+ T cells are critical for corneal, but not skin, allograft rejection. Transplantation. 2000;69:483-487.
19. Xu M, Lepisto AJ, Hendricks RL. CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas. J Immunol. 2004;173:1232-1239.
20. Khanna KM, Bonneau RH, Kinchington PR, et al. Herpes simplex virus-specific memory CD8 T cells are selectively activated and retained in latently infected sensory ganglia. Immunity. 2003;18:593-603.
21. Liu T, Khanna KM, Chen X, et al. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med. 2000;191:1459-1466.
22. Shimeld C, Whiteland JL, Nicholls SM, et al. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol. 1995;61:7-16.
23. Cantin EM, Hinton DR, Chen J, et al. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol. 1995;69:4898-4905.
24. Halford WP, Gebhardt BM, Carr DJ. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology. 1997;238:53-63.
25. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339-342.
26. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337-339.
27. Stuart PM, Summers B, Morris JE, et al. CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol. 2004;85:2055-2063.